Click Holdings Limited (NASDAQ:CLIK) Sees Significant Growth in Short Interest

Click Holdings Limited (NASDAQ:CLIK) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totaling 56,063 shares, an increase of 252.9% from the March 31st total of 15,886 shares. Currently, 4.9% of the shares of the stock are short sold. Based on an average trading volume of 3,874,079 shares, the days-to-cover ratio is currently 0.0 days.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of Click in a research note on Friday, March 27th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has a consensus rating of “Sell”.

Click Stock Down 7.1%

NASDAQ CLIK traded down $0.21 during trading on Friday, hitting $2.75. 82,450 shares of the company’s stock were exchanged, compared to its average volume of 4,094,114. The stock’s 50 day moving average price is $2.84 and its two-hundred day moving average price is $4.83. Click has a fifty-two week low of $1.32 and a fifty-two week high of $34.20.

About Click

Click Therapeutics, Inc (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.

Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review.